Extracellular ATP, P2 receptors, and inflammation

Francesco Di Virgilio, Davide Ferrari, Marco Idzko, Elisabeth Panther, Johannes Norgauer, Andrea La Sala, Giampiero Girolomoni

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Over the past few years, P2 receptors have emerged as new potential players in the early phases of inflammation in their function of chemotactic receptors, triggers of proinflammatory cytokine release, and cytotoxic molecules. However, more recent data suggest that the role of P2 receptors in immunity is much more widespread and touches the very heart of the initiation of the immune response, i.e., antigen presentation by dendritic cells.

Original languageEnglish
Pages (from-to)171-174
Number of pages4
JournalDrug Development Research
Volume59
Issue number1
DOIs
Publication statusPublished - May 1 2003

Fingerprint

Purinergic P2 Receptors
Histocompatibility Antigens Class II
Antigen Presentation
Touch
Dendritic Cells
Immunity
Adenosine Triphosphate
Cytokines
Inflammation
Antigens
Molecules

Keywords

  • Allergy
  • Dendritic cells
  • EctoATPase
  • Immunity
  • Purinergic receptors

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Di Virgilio, F., Ferrari, D., Idzko, M., Panther, E., Norgauer, J., La Sala, A., & Girolomoni, G. (2003). Extracellular ATP, P2 receptors, and inflammation. Drug Development Research, 59(1), 171-174. https://doi.org/10.1002/ddr.10191

Extracellular ATP, P2 receptors, and inflammation. / Di Virgilio, Francesco; Ferrari, Davide; Idzko, Marco; Panther, Elisabeth; Norgauer, Johannes; La Sala, Andrea; Girolomoni, Giampiero.

In: Drug Development Research, Vol. 59, No. 1, 01.05.2003, p. 171-174.

Research output: Contribution to journalArticle

Di Virgilio, F, Ferrari, D, Idzko, M, Panther, E, Norgauer, J, La Sala, A & Girolomoni, G 2003, 'Extracellular ATP, P2 receptors, and inflammation', Drug Development Research, vol. 59, no. 1, pp. 171-174. https://doi.org/10.1002/ddr.10191
Di Virgilio F, Ferrari D, Idzko M, Panther E, Norgauer J, La Sala A et al. Extracellular ATP, P2 receptors, and inflammation. Drug Development Research. 2003 May 1;59(1):171-174. https://doi.org/10.1002/ddr.10191
Di Virgilio, Francesco ; Ferrari, Davide ; Idzko, Marco ; Panther, Elisabeth ; Norgauer, Johannes ; La Sala, Andrea ; Girolomoni, Giampiero. / Extracellular ATP, P2 receptors, and inflammation. In: Drug Development Research. 2003 ; Vol. 59, No. 1. pp. 171-174.
@article{9874ef27a6294a8aa9e9d884208820f6,
title = "Extracellular ATP, P2 receptors, and inflammation",
abstract = "Over the past few years, P2 receptors have emerged as new potential players in the early phases of inflammation in their function of chemotactic receptors, triggers of proinflammatory cytokine release, and cytotoxic molecules. However, more recent data suggest that the role of P2 receptors in immunity is much more widespread and touches the very heart of the initiation of the immune response, i.e., antigen presentation by dendritic cells.",
keywords = "Allergy, Dendritic cells, EctoATPase, Immunity, Purinergic receptors",
author = "{Di Virgilio}, Francesco and Davide Ferrari and Marco Idzko and Elisabeth Panther and Johannes Norgauer and {La Sala}, Andrea and Giampiero Girolomoni",
year = "2003",
month = "5",
day = "1",
doi = "10.1002/ddr.10191",
language = "English",
volume = "59",
pages = "171--174",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Extracellular ATP, P2 receptors, and inflammation

AU - Di Virgilio, Francesco

AU - Ferrari, Davide

AU - Idzko, Marco

AU - Panther, Elisabeth

AU - Norgauer, Johannes

AU - La Sala, Andrea

AU - Girolomoni, Giampiero

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Over the past few years, P2 receptors have emerged as new potential players in the early phases of inflammation in their function of chemotactic receptors, triggers of proinflammatory cytokine release, and cytotoxic molecules. However, more recent data suggest that the role of P2 receptors in immunity is much more widespread and touches the very heart of the initiation of the immune response, i.e., antigen presentation by dendritic cells.

AB - Over the past few years, P2 receptors have emerged as new potential players in the early phases of inflammation in their function of chemotactic receptors, triggers of proinflammatory cytokine release, and cytotoxic molecules. However, more recent data suggest that the role of P2 receptors in immunity is much more widespread and touches the very heart of the initiation of the immune response, i.e., antigen presentation by dendritic cells.

KW - Allergy

KW - Dendritic cells

KW - EctoATPase

KW - Immunity

KW - Purinergic receptors

UR - http://www.scopus.com/inward/record.url?scp=0037636450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037636450&partnerID=8YFLogxK

U2 - 10.1002/ddr.10191

DO - 10.1002/ddr.10191

M3 - Article

AN - SCOPUS:0037636450

VL - 59

SP - 171

EP - 174

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 1

ER -